BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9886850)

  • 1. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity.
    Camp HS; Tafuri SR; Leff T
    Endocrinology; 1999 Jan; 140(1):392-7. PubMed ID: 9886850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient.
    Hazzalin CA; Cano E; Cuenda A; Barratt MJ; Cohen P; Mahadevan LC
    Curr Biol; 1996 Aug; 6(8):1028-31. PubMed ID: 8805335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.
    Camp HS; Tafuri SR
    J Biol Chem; 1997 Apr; 272(16):10811-6. PubMed ID: 9099735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells.
    Akaike M; Che W; Marmarosh NL; Ohta S; Osawa M; Ding B; Berk BC; Yan C; Abe J
    Mol Cell Biol; 2004 Oct; 24(19):8691-704. PubMed ID: 15367687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1.
    Asada S; Daitoku H; Matsuzaki H; Saito T; Sudo T; Mukai H; Iwashita S; Kako K; Kishi T; Kasuya Y; Fukamizu A
    Cell Signal; 2007 Mar; 19(3):519-27. PubMed ID: 17113751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1.
    Lim CP; Jain N; Cao X
    Oncogene; 1998 Jun; 16(22):2915-26. PubMed ID: 9671412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
    Sung CK; She H; Xiong S; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells.
    Stadheim TA; Kucera GL
    Leuk Res; 2002 Jan; 26(1):55-65. PubMed ID: 11734304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways.
    Knebel A; Haydon CE; Morrice N; Cohen P
    Biochem J; 2002 Oct; 367(Pt 2):525-32. PubMed ID: 12171600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
    Krause D; Lyons A; Fennelly C; O'Connor R
    J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt.
    Han YH; Cao X; Lin B; Lin F; Kolluri SK; Stebbins J; Reed JC; Dawson MI; Zhang XK
    Oncogene; 2006 May; 25(21):2974-86. PubMed ID: 16434970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.
    Adams M; Reginato MJ; Shao D; Lazar MA; Chatterjee VK
    J Biol Chem; 1997 Feb; 272(8):5128-32. PubMed ID: 9030579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.
    Zhang B; Berger J; Zhou G; Elbrecht A; Biswas S; White-Carrington S; Szalkowski D; Moller DE
    J Biol Chem; 1996 Dec; 271(50):31771-4. PubMed ID: 8943212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ras transformation on the induction of the IL-1 receptor related T1 gene in response to mitogens, anisomycin, IL-1 and TNFalpha.
    Laursen NB; Kessler R; Fröhli E; Klemenz R
    Oncogene; 1998 Feb; 16(5):575-86. PubMed ID: 9482103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage.
    Bost F; Caron L; Marchetti I; Dani C; Le Marchand-Brustel Y; Binétruy B
    Biochem J; 2002 Feb; 361(Pt 3):621-7. PubMed ID: 11802792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
    Ishikawa Y; Kitamura M
    Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.